- Dame Sarah Catherine Gilbert
- Professor of Vaccinology at Jenner Institute, University of Oxford
Dame Sarah Catherine Gilbert, Professor of Vaccinology at Jenner Institute, University of Oxford, is a scientist who co-developed the Oxford-AstraZeneca coronavirus vaccine, which is easier and less expensive to manufacture, store and transport.
More than 2.5 billion doses of the Oxford-AstraZeneca vaccine have been delivered to 182 nations across every continent as of January 2022, playing a vital role in protecting the lives of people in low-income countries with weak healthcare systems.
Approached vaccine as global public goods and contributed to saving lives in low-income nations by delivering over 2.5 billion doses of vaccine at low-cost
Dame Sarah Gilbert, Professor of Vaccinology at the Jenner Institute, University of Oxford, viewed the Covid-19 pandemic as a common threat to humanity and approached vaccine as a global public good. She stood firm that vaccine sale was not for profit and contracted with AstraZeneca who pledged to manufacture and distribute the vaccine at low cost. The Oxford-AstraZeneca vaccine is easier and less expensive to manufacture, store and transport; over 2.5 billion doses have been delivered to 182 nations around the globe as of January 2022, playing a vital role in protecting the lives of people in low-income countries with less medical aid.
Developed the revolutionary 'plug-and-play' method that rapidly designs vaccines against new viruses to protect humanity from ‘Disease -X’
Professor Dame Sarah Gilbert has been working for over 25 years on designing vaccines against infectious diseases such as Middle East Respiratory Syndrome (MERS), Crimean Congo Hemorrhagic Fever (CCHF), Nipah virus, and Lassa fever. Realizing the importance of speed in overcoming infectious diseases, she developed the ‘plug and play’ method to design a vaccine. Based on her years of scientific research to prepare for a future epidemic of ‘Disease-X’ before the Covid-19 outbreak, her team was able to design a Covid-19 vaccine in early 2020, just 2 weeks after the outbreak.
Dame Sarah Catherine Gilbert
- April 1962
- United Kingdom
- Awarded for
- Co-Developer of Oxford-AstraZeneca Vaccine
Approached vaccine as global public goods
Protecting humanity from ‘Diseases -X’
Bachelor of Science in Biological Sciences, University of East Anglia
Ph.D. in Biochemistry, University of Hull
Honorary Doctorate of Science, University of East Anglia
Research Scientist, Brewing Research Foundation
Research Scientist, Leicester Biocentre, Leicester University
Research Scientist, Delta Biotechnology Ltd.
Senior Molecular Biologist, Nuffield Department of Medicine, University of Oxford
Lecturer, University of Oxford
Reader in Vaccinology, University of Oxford
Jenner Investigator, University of Oxford
Received flu vaccine development project grant from Wellcome Trust; Program Manager, Wellcome Trust Strategic Award on Human and Veterinary Vaccine Development
Professor of Vaccinology, Jenner Institute, Nuffield Department of Medicine, University of Oxford
Co-founded Vaccitech with Adrian V.S. Hill, a biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer
Humanists UK Rosalind Franklin Medal
Albert Medal of the Royal Society of Arts
Dame Commander of the Order of the British Empire
Princess of Asturias Award for Technical & Scientific Research
Royal Society of Medicine Gold Medal
Erna Hamburger Prize
『Vaxxers 』Professor Sarah Gilbert and Dr. Catherine Green, 2021.